Bristol Myers Squibb has completed the previously announced sale of its manufacturing facility in Syracuse, NY to Lotte Biologics. The divestiture is part of Bristol Myers Squibb’s ongoing evolution of its manufacturing network to support its product portfolio. As part of the transaction, Lotte Biologics has offered all employees at the site employment within its […]

The post Bristol Myers Squibb Completes Sale of Manufacturing Facility in Syracuse, NY first appeared on World Pharma Today.